Prestige Consumer Healthcare Inc.PBHNYSE
Loading

Latest News

Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips
globenewswire.com

Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips

TARRYTOWN, N.Y., March 20, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced that it has entered into a definitive agreement to acquire the Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated tax benefits valued at $150 million.

3 Stocks That Could Be Easy Wealth Builders
fool.com

3 Stocks That Could Be Easy Wealth Builders

These companies acquire established consumer brands with loyal customers, then improve margins and cash flow through efficiency efforts. Pet care, lawn and garden, and OTC healthcare products generate consistent demand, making these easy long-term wealth builders.

Heartland Opportunistic Value Equity Strategy Q4 2025 Portfolio Activity
seekingalpha.com

Heartland Opportunistic Value Equity Strategy Q4 2025 Portfolio Activity

One profitable company whose shares we've held for years, and that demonstrates why a focus on shareholder value creation matters in the long run, is Old Republic International. A new mid-cap holding in the quarter was Prestige Consumer Healthcare, whose over-the-counter brands are familiar to many. A multi-year holding that has struggled recently is Watsco, the largest wholesale distributor of HVAC and refrigeration equipment in the United States.

Premium Brands: Setting Expectations For 2026 And Beyond
seekingalpha.com

Premium Brands: Setting Expectations For 2026 And Beyond

Premium Brands (PBH:CA) remains a 'Hold' with a price target near $110, reflecting market-like performance expectations into FY 2026. PBH's $10B revenue target hinges on organic growth and disciplined M&A, but high leverage and ongoing Capex constrain aggressive expansion. Organic volume growth outpaced pricing, driving a 19% sales jump, but EBITDA margins remain pressured by elevated beef costs and new plant overhead.

PBH vs. A: Which Stock Is the Better Value Option?
zacks.com

PBH vs. A: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?